Differential DNA Methylation in the Alzheimer’s Disease Brain (Erica Soboslay, Danielle Brokaw, James Tuohy and Paul Coleman)DNA methylation is an epigenetic modification that can alter gene expression without changing the underlying nucleotide sequence. 5-methylcytosine is formed by the binding of a methyl group to the cytosine base of CpG dinucleotides. These modifications may inhibit gene transcription, particularly when present at transcription start sites. Differential DNA methylation has been associated with many human diseases including Alzheimer’s disease (AD; Bradley-Whitman & Lovell, 2013; Coppieters et al., 2013; De Jager et al., 2014; Lunnon et al., 2014; Mastroeni et al., 2010; Van den Hove et al., 2013) although the exact role of epigenetic modifications in the pathology of these diseases has yet to be elucidated. In this study DNA methylation was assayed with an Illumina 450K microarray containing samples from the middle temporal gyrus (MTG) and cerebellum (CBL) of human post-mortem brain. 121 female and 99 male participants with AD neuropathology (n= 220) and 75 female and 98 male participants without AD neuropathology (n= 173), were represented on the microarray, with each subject contributing a MTG and a CBL sample. Raw data was preprocessed and normalized in the R programming platform employing the Minfi package from Bioconductor (Aryee et al., 2014). Local (DMP) and regional (DMR) methylation was detected using the Minfi peak analysis and bumphunter algorithms, respectively. Significant DMPs were determined by false discovery rate qvalue cutoff 0.05 and significant DMRs by family wise error rate cutoff of 0.05. Significant DMRs and DMPs were determined statistically in terms of brain region, disease state, and gender. The biological relevance of each significant DMP and DMR was determined using the UCSC Genome Browser. DMR analysis revealed 137 CpGs to be significantly associated with disease state, 75 of which were specific to the CBL, and 62 to the MTG. Of the 137 CpGs, 42 were found to be significantly correlated with disease in both the CBL and MTG. Statistical analysis of DMRs determined 93 CpG sites were affected by gender state, 53 of which were specific to the MTG and 40 to the CBL. 20 CpGs were significantly correlated with gender in both the CBL and MTG. Five DMRs were found to be significantly correlated with disease, an additional 15 DMRs were significant with respect to gender and disease, and seven additional DMRs were significantly associated with brain region, gender, and disease. Genes found to correspond to disease-associated DMRs include the previously reported AD gene, HLA-DRB5 (Yu et al., 2015), as well as CCDC140, TLX3, HLA-DQA1, ZFP57, ZNF596, RPH3AL and OTX2. This study has described changes in the DNA methylation state of CBL and MTG of participants with AD, determined statistical significance with respect to brain region, disease, and gender, and utilized this information to make novel contributions to the growing list of AD epigenetic signatures.